These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26200480)

  • 21. Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer.
    Min BD; Kim WT; Cho BS; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2012 Dec; 53(12):830-5. PubMed ID: 23301126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.
    Rischke HC; Nestle U; Fechter T; Doll C; Volegova-Neher N; Henne K; Scholber J; Knippen S; Kirste S; Grosu AL; Jilg CA
    Radiat Oncol; 2013 Jul; 8():183. PubMed ID: 23875672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
    Alonzo F; Melodelima C; Bratan F; Vitry T; Crouzet S; Gelet A; Rouvière O
    Diagn Interv Imaging; 2016 Apr; 97(4):433-41. PubMed ID: 26928245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of MRI and added value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of local recurrence from rectal cancer.
    Molinelli V; Angeretti MG; Duka E; Tarallo N; Bracchi E; Novario R; Fugazzola C
    Abdom Radiol (NY); 2018 Nov; 43(11):2903-2912. PubMed ID: 29541831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
    Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
    AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of diffusion-weighted MRI in diagnosis of uterine cervical cancer: a prospective study evaluating the benefits of DWI compared to conventional MR sequences in a 3T environment.
    Exner M; Kühn A; Stumpp P; Höckel M; Horn LC; Kahn T; Brandmaier P
    Acta Radiol; 2016 Jul; 57(7):869-77. PubMed ID: 26329683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
    Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
    Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine cervical cancer volumetry using T2- and diffusion-weighted MR images in patients treated by primary surgery and neoadjuvant chemotherapy.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Saida T; Minami M; Yoshikawa H
    Acta Radiol; 2016 Mar; 57(3):378-83. PubMed ID: 25838450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of pelvic recurrence from colorectal cancer.
    Colosio A; Soyer P; Rousset P; Barbe C; Nguyen F; Bouché O; Hoeffel C
    J Magn Reson Imaging; 2014 Aug; 40(2):306-13. PubMed ID: 24311014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.
    Lin G; Huang YT; Chao A; Lin YC; Yang LY; Wu RC; Lu HY; Ng SH; Ng KK; Lai CH
    Eur Radiol; 2017 May; 27(5):1867-1876. PubMed ID: 27631107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of diffusion-weighted MR imaging in the diagnosis of placenta accreta spectrum abnormality.
    Sannananja B; Ellermeier A; Hippe DS; Winter TC; Kang SK; Lee SI; Kilgore MR; Dighe MK
    Abdom Radiol (NY); 2018 Nov; 43(11):3147-3156. PubMed ID: 29666952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.